Solid Biosciences Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Good afternoon. It's now my pleasure to introduce our next fireside chat guest. From Solid Biosciences, we have Dr. Carl Morris, Chief Scientific Officer; and Dr. Joel Schneider, Chief Operating Officer. (Operator Instructions). Thank you both for joining us today. Please go ahead with your overview and then we will dive into the Q&A.
Thank you, Geulah. And thank you to the Chardan Conference for hosting us and giving us this opportunity to talk about all the current ongoings at Solid, and to provide a bit of a corporate recap of where we are in the development of our promising programs for Duchenne muscular dystrophy. I will just provide a quick overview over a few slides of the work that we're currently going through, and then would love to dive into the Q&A with you, Geulah. I will skip over the forward-looking statements.
As a quick introduction for those of you that are not familiar with Solid, we consider ourselves innovators in gene
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
